CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
Net sales	$ 15,283	$ 5,267	$ 30,540	$ 8,962
Cost of sales	8,886	3,373	17,343	6,464
Gross profit	6,397	1,894	13,197	2,498
Operating expenses:
Selling, general and administrative	2,612	1,643	7,054	4,658
Research and development	1,529	903	4,163	2,623
Total operating expenses	4,141	2,546	11,217	7,281
Income (loss) from operations	2,256	(652)	1,980	(4,783)
Interest income (expense), net	1	(10)	(9)	(35)
Net gain from dissolution of Aehr Test Systems Japan	0	0	0	2,186
Gain from forgiveness of PPP loan	0	0	1,698	0
Other income (expense), net	10	(39)	68	(139)
Income (loss) before income tax (expense) benefit	2,267	(701)	3,737	(2,771)
Income tax (expense) benefit	(24)	(34)	(81)	177
Net income (loss)	$ 2,243	$ (735)	$ 3,656	$ (2,594)
Net income (loss) per share
Earnings Per Share Basic	$ 0.08	$ (0.03)	$ 0.14	$ (0.11)
EarningsPerShareDiluted	$ 0.08	$ (0.03)	$ 0.13	$ (0.11)
Shares used in per share calculations:
Basic	26,871	23,525	25,684	23,390
Diluted	28,854	23,525	27,510	23,390